financetom
Business
financetom
/
Business
/
Mistras Group Insider Sold Shares Worth $404,216, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mistras Group Insider Sold Shares Worth $404,216, According to a Recent SEC Filing
Sep 21, 2024 8:21 PM

04:20 PM EDT, 09/20/2024 (MT Newswires) -- Michael J. Lange, Senior Executive Vice President, on September 16, 2024, sold 37,806 shares in Mistras Group ( MG ) for $404,216. Following the Form 4 filing with the SEC, Lange has control over a total of 302,709 shares of the company, with 302,709 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1436126/000112760224024277/xslF345X05/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MicroStrategy Unusual Options Activity
MicroStrategy Unusual Options Activity
Oct 23, 2024
Financial giants have made a conspicuous bearish move on MicroStrategy ( MSTR ). Our analysis of options history for MicroStrategy ( MSTR ) revealed 20 unusual trades. Delving into the details, we found 30% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $305,687, and 16...
Update: Eli Lilly's Alzheimer's Treatment Donanemab Deemed Not Cost-Effective for NHS use, UK Health Body Says
Update: Eli Lilly's Alzheimer's Treatment Donanemab Deemed Not Cost-Effective for NHS use, UK Health Body Says
Oct 23, 2024
09:47 AM EDT, 10/23/2024 (MT Newswires) -- (Updates to add Eli Lilly's ( LLY ) comment in the last paragraph.) Eli Lilly's ( LLY ) new treatment for mild Alzheimer's disease donanemab requires more evidence on its clinical and cost-effectiveness and cannot currently be considered good value for the UK's National Health Service, the National Institute for Health and Care...
Bank of America Says AI Patent Portfolio Grew 94% Since 2022
Bank of America Says AI Patent Portfolio Grew 94% Since 2022
Oct 23, 2024
09:45 AM EDT, 10/23/2024 (MT Newswires) -- Bank of America ( BAC ) said Wednesday its portfolio of artificial intelligence and machine learning patents has grown by 94% since 2022. The company, which holds nearly 7,000 patents across various technologies, said it now has about 1,100 patents and pending applications related to AI and machine learning, with more than half...
Banks Sue CFPB Over Financial Data Rule
Banks Sue CFPB Over Financial Data Rule
Oct 23, 2024
09:49 AM EDT, 10/23/2024 (MT Newswires) -- The Bank Policy Institute and the Kentucky Bankers Association filed a lawsuit Wednesday against the Consumer Financial Protection Bureau, challenging portions of the regulator's rulemaking governing how consumers access their financial data and how that data is protected. The lawsuit, filed in U.S. District Court in Lexington, Kentucky, asserts the CFPB overstepped its...
Copyright 2023-2026 - www.financetom.com All Rights Reserved